On Tuesday shares of XBIOTECH INC. (NASDAQ:XBIT) closed at $18.20. XBiotech (NASDAQ:XBIT) announced 29 April, that it has enrolled the first patient into its revised U.S. Phase 3 study of Xilonix™ in metastatic colorectal cancer patients. Xilonix, XBiotech’s monoclonal True Human antibody therapy, is designed to block chronic inflammation associated with malignant tumor growth.
AK Steel Holding Corporation (NYSE:AKS) in last trading activity moved up 4.03% to close at $5.42. Company weekly performance is 1.31% while its quarterly performance stands at 27.53%. AK Steel Holding Corporation (NYSE:AKS) is -52.33% away from its 52 week high. On 28 April, AK Steel Holding Corporation (NYSE:AKS) reported a net loss of $306.3 million or $1.72 per share in first-quarter 2015 compared with a loss of $86.1 million or 63 cents per share in the year-ago quarter.
On Tuesday shares of Goldcorp Inc. (NYSE:GG) closed at $18.54. Company’s sales growth for last 5 years was 4.80% and EPS growth for next 5 years is recorded as 11.10%. Goldcorp Inc. (NYSE:GG) reported weaker earnings on 30 April, that fell well short of analyst expectations, as lower prices along with higher taxes and costs more than offset increased production from its mines. On a net basis, Goldcorp lost $87 million, or 11 cents per share, compared with net earnings of $98 million, or 12 cents per share. All-in sustaining costs to produce one ounce of gold was $885 in the quarter, up from $840 last year. This measure, adopted by producers in 2013, includes sustaining capital, exploration costs and general expenses. Gold production rose to 724,800 ounces from 679,000 ounces, but the average realized price dropped to $1,217 per ounce from $1,297 an ounce.
RetailMeNot, Inc. (NASDAQ:SALE) has 1.40% insider ownership while its institutional ownership stands at 87.70%. In last trading activity company’s stock closed at $20.09. Analysts at RBC Capital set a $21.00 price target on shares of RetailMeNot Inc. (NASDAQ:SALE) and gave the company a “hold” rating in a research note on Tuesday.
On last trading day China Biologic Products, Inc. (NASDAQ:CBPO) moved up 1.19% to close at $98.48. Its volatility for the week is 3.24% while volatility for the month is 3.45%. CBPO’s sales growth for past 5 years was 15.40% and its EPS growth for past 5 years was 93.50%. China Biologic Products, Inc. (NASDAQ:CBPO) monthly performance is 6.25%. China Biologic Products, Inc. (NASDAQ:CBPO) announced that the Company plans to release first quarter 2015 financial results on Wednesday, May 6, 2015 after the market closes.